Abstract
ELISAs and similar immunoassays are a backbone of biomedical research and clinical practice. Here we review the major factors to consider in the development and application of ultrasensitive ELISAs for analysis of human immune responses in plasma, serum, urine, or tissue culture supernatants. We focus on cytokine and chemokine biomarkers of health and chronic inflammatory diseases including allergy, asthma, autoimmunity, and cardiovascular disease. Detailed protocols for ELISA and Meso Scale Discovery assays (an improved variant of ELISA) are provided for 15 cytokines and 11 chemokines that play immune-regulatory roles in human innate and adaptive immunity. Protocols have been individually optimized to yield ultrasensitive limits of detection and quantification. Major factors enhancing immunoassay sensitivity, precision, and reproducibility, as well as key pitfalls in assay design and execution, are critically reviewed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
HayGlass KT (2012) Complex asthma endotypes, differential chemokine responses and birth cohort studies: solving equations with multiple variables. Clin Exp Allergy 42(11):1546–1548
HayGlass KT (2011) The quest for predictive immune biomarkers. Clin Exp Allergy 41(12):1656–1659
Maciejko L, Smalley M, Goldman A (2017) Cancer immunotherapy and personalized medicine: emerging technologies and biomarker-based approaches. J Mol Biomark Diagn 8(5):350
Alexis NE (2014) Biomarker sampling of the airways in asthma. Curr Opin Pulm Med 20(1):46–52
Tunceroglu H, Shah A, Porhomayon J et al (2013) Biomarkers of lung injury in critical care medicine: past, present, and future. Immunol Investig 42(3):247–261
Easton R, Balogh ZJ (2014) Peri-operative changes in serum immune markers after trauma: a systematic review. Injury 45(6):934–941
Massaro AN, Wu YW, Bammler TK et al (2018) Plasma biomarkers of brain injury in neonatal hypoxic-ischemic encephalopathy. J Pediatr 194:67–75 e1
Dhondalay GK, Rael E, Acharya S et al (2018) Food allergy and omics. J Allergy Clin Immunol 141(1):20–29
Prasad G, McCullough M (2013) Chemokines and cytokines as salivary biomarkers for the early diagnosis of oral cancer. Int J Dent 2013:813756
Rodney T, Osier N, Gill J (2018) Pro- and anti-inflammatory biomarkers and traumatic brain injury outcomes: a review. Cytokine 110:248–256. https://doi.org/10.1016/j.cyto.2018.01.012
Henriksen K, O’Bryant SE, Hampel H et al (2014) The future of blood-based biomarkers for Alzheimer’s disease. Alzheimers Dement 10(1):115–131
Yalow RS, Berson SA (1960) Immunoassay of endogenous plasma insulin in man. J Clin Invest 39:1157–1175
Imada M, Simons FE, Jay FT et al (1995) Antigen mediated and polyclonal stimulation of human cytokine production elicit qualitatively different patterns of cytokine gene expression. Int Immunol 7(2):229–237
Acknowledgments
We thank the many colleagues and collaborators who have provided suggestions which aided in the development of these methodologies. We acknowledge funding from the CIHR (Canadian Institutes for Health Research) and the Canada Research Chairs program.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Stefura, W.P., Graham, C., Lotoski, L., HayGlass, K.T. (2019). Improved Methods for Quantifying Human Chemokine and Cytokine Biomarker Responses: Ultrasensitive ELISA and Meso Scale Electrochemiluminescence Assays. In: Lympany, P., Jones, M. (eds) Allergy. Methods in Molecular Biology, vol 2020. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9591-2_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9591-2_7
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9589-9
Online ISBN: 978-1-4939-9591-2
eBook Packages: Springer Protocols